Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Danielle E Baranova"'
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0190026 (2018)
Vibrio cholerae O1 is one of two serogroups responsible for epidemic cholera, a severe watery diarrhea that occurs after the bacterium colonizes the human small intestine and secretes a potent ADP-ribosylating toxin. Immunity to cholera is associated
Externí odkaz:
https://doaj.org/article/04e4638a50104754a97ba9e3560150a3
Publikováno v:
Pathogens and Immunity, Vol 5, Iss 1, Pp 89-116 (2020)
Background: In cholera epidemics, the spread of disease can easily outpace vaccine control measures. The advent of technologies enabling the expression of recombinant proteins, including antibodies, in the milk of transgenic animals raises the prospe
Externí odkaz:
https://doaj.org/article/4ba14b90c6584124a770802db34cdfeb
Autor:
Jennifer Doering, Nicholas J. Mantis, Matteo Samuele Pizzuto, Fabio Benigni, Graham G. Willsey, Davide Corti, Fernando J Torres-Velez, Stefano Jaconi, Angelene F. Richards, Danielle E. Baranova
Publikováno v:
ACS Infectious Diseases
As the predominant antibody type in mucosal secretions, human colostrum, and breast milk, secretory IgA (SIgA) plays a central role in safeguarding the intestinal epithelium of newborns from invasive enteric pathogens like the Gram-negative bacterium
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::704da1dd01a2c0104232153d73eebb66
https://doi.org/10.1021/acsinfecdis.0c00842
https://doi.org/10.1021/acsinfecdis.0c00842
Publikováno v:
Human vaccinesimmunotherapeutics. 18(2)
Eliminating diarrheal diseases as a leading cause of childhood morbidity and mortality in low- and middle-income countries (LMICs) will require multiple intervention strategies. In this review, we spotlight a series of preclinical studies investigati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ef5cf51b674066fe6e2bef88d4e8cab
https://pubmed.ncbi.nlm.nih.gov/34491878
https://pubmed.ncbi.nlm.nih.gov/34491878
Autor:
Carol Smith, Graham G. Willsey, Joseph T. Wade, Kara J. Levinson, Nicholas J. Mantis, Danielle E. Baranova
Publikováno v:
Pathog Dis
Following an episode of cholera, a rapidly dehydrating, watery diarrhea caused by the Gram-negative bacterium, Vibrio cholerae O1, humans mount a robust anti-lipopolysaccharide (LPS) antibody response that is associated with immunity to subsequent re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd3e2436821a95c2ed45923aa706533e
https://europepmc.org/articles/PMC7371154/
https://europepmc.org/articles/PMC7371154/
Publikováno v:
Vaccine. 34:5833-5836
Vibrio cholerae is the causative agent of cholera, an acute diarrheal disease that remains endemic in many parts of the world. The mechanisms underlying immunity to cholera remain poorly defined, though it is increasingly clear that protection is ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f35e9819f7390a9c42e66119b6d2443d
https://doi.org/10.1016/j.vaccine.2016.10.023
https://doi.org/10.1016/j.vaccine.2016.10.023
Autor:
Margaret M. Destrempes, Harry M. Meade, Nicholas J. Mantis, Li-How Chen, Danielle E. Baranova
Publikováno v:
Pathogens and Immunity. 5:89
Background: In cholera epidemics, the spread of disease can easily outpace vaccine control measures. The advent of technologies enabling the expression of recombinant proteins, including antibodies, in the milk of transgenic animals raises the prospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82a77fff4115af58890e314941b08872
https://doi.org/10.20411/pai.v5i1.370
https://doi.org/10.20411/pai.v5i1.370